Skip to main content
Premium Trial:

Request an Annual Quote

EraGen Raises $12M in Series A Private Equity round

NEW YORK, Jan. 9 (GenomeWeb News) - EraGen Biosciences raised $12 million in Series A financing, the company announced today.


Investors in this round included Novartis Venture Fund, First Analysis, Prolog Ventures, Stonehenge Capital, and a syndicate of investors from the Midwest.


EraGen also said Tracy Marshbanks from First Analysis and Greg Johnson from Prolog Ventures have joined the company's board of directors.


With this funding, the company has raised approximately $21 million to date.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.